| Invasive Bladder Urothelial Carcinoma studied in …STUDIED_INderived45 of 45show fewer |
|---|
| → studied in | NCT03866382Phase 2 · recruiting Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05987241Phase 2/Phase 3 · recruiting Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061964Phase 2 · recruiting Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06770582Phase 2 · recruiting Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605404recruiting Pan-tumor MRD Study · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332351Phase 2 · not yet recruiting Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07667335Phase 1/Phase 2 · recruiting Enfortumab Vedotin, Pembrolizumab and Quemliclustat for the Treatment of Unresectable Locally Advanced and Metastatic Urothelial Cancer · condition mapped CURATED_BROADER · 45 trials mapped (31 active) | — | — | Invasive Bladder Giant Cell Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822373Phase 2 · not yet recruiting A Phase 2 Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02812420early Phase 1 · active not recruiting Durvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before Surgery · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503614Phase 2 · recruiting A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Invasive Bladder Plasmacytoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07097142Phase 3 · recruiting Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07726602recruiting Tumor-informed ctDNA in Muscle-invasive Bladder Cancer for Evaluation of Residual/Recurrent Disease - the TiMBER Trial · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164082Phase 2 · active not recruiting Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05483868Phase 1 · active not recruiting A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809140Phase 2 · recruiting Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05833867Phase 1 · recruiting Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer · condition mapped CURATED_BROADER · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03744793Phase 2 · active not recruiting Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05521698Phase 1 · recruiting A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07302230NA · recruiting Home-Based Physical Activity Program With Digital App Versus Health Education Group for Improving Physical Activity Among Patients With Non-muscle Invasive Bladder Cancer, The EMPOWER Trial · condition mapped CURATED_BROADER · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06204614early Phase 1 · enrolling by invitation Drug Screening Using IMD in Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04878029Phase 1 · recruiting Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma with Squamous Differentiation | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05700227NA · terminated Daily Online Adaptive Short-Course Radiation Therapy and Concurrent Chemotherapy for Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03609216Phase 2 · active not recruiting Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01616875Phase 2 · completed Bristol Bladder Trial · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05962541Phase 4 · recruiting Vesical Imaging-Reporting and Data System (VI-RADS) Followed by Photodynamic Trans-urethral Resection of Bladder Tumours (PDD-TURBT) to Avoid Secondary Resections (Re-TURBT) in Non-Muscle Invasive Bladder Cancers (NMIBCs) · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07279597Phase 2 · not yet recruiting A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06396533recruiting Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01495676NA · terminated A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07064863Phase 1/Phase 2 · not yet recruiting A Tumor Immune Biomarker Guided Approach for Improving Response to BCG in Patients With High-risk NMIBC. · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06257017Phase 2 · recruiting Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06766266Phase 1 · recruiting Irinotecan Liposomes Combined with Epirubicin in Recurrent Non-muscle Invasive Bladder Urothelium Carcinoma After Anthracyclines Treatment · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03549715Phase 1/Phase 2 · unknown NEoadjuvant Dose-dense MVAC In cOmbination With Durvalumab and Tremelimumab in Muscle-invasive Urothelial Carcinoma · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04496219Phase 2 · completed Acupuncture for the Treatment of Intravesical BCG-Related Adverse Events in High-Risk Non-muscle Invasive Bladder Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06170177recruiting Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06167356recruiting Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK. · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03912818Phase 2 · terminated Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Sarcomatoid Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06020807completed Analytical Specificity of Bladder EpiCheck Test in Healthy Population and Urology Patients Without Prior History or Evidence of Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05946369completed Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02767921Phase 1 · terminated sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04730232Phase 2 · unknown Tilelizumab Combined With Nab-Paclitaxel for High-Risk Non-Muscle-Invasive Urothelial Bladder Carcinoma Which is Not Completely Resectable · condition mapped ONTOLOGY_EXACT · 45 trials mapped (31 active) | — | — | Non-Muscle Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02688348NA · withdrawn Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03419130Phase 2 · withdrawn Radiation Therapy and Pembrolizumab in Treating Patients With Localized Urothelial Bladder Cancer · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03238664NA · withdrawn Robot-Assisted Laparoscopic High-Intensity Focused Ultrasound and Radical Cystectomy for Thermal Ablation of Muscle Invasive Cells in Patients With Bladder Tumors · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02944357NA · withdrawn Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery · condition mapped ALIAS · 45 trials mapped (31 active) | — | — | Invasive Bladder Urothelial Carcinoma | 1 | Observed | clinicaltrials | graph → |